Defining the bone marrow atlas with high-dimensional biology via a novel CITE-seq workflow

Now Watchinghttps://youtu.be/hD4OV9vf-Ak Single-cell multimodal approaches and machine learning are transforming analysis of the human hematopoietic progenitor compartment. Cellular indexing of transcriptomes and epitopes by sequencing (CITE-seq) enables coupled surface protein and transcriptome profiling, revealing genomic programs underlying progenitor states. This webinar will present groundbreaking work establishing a high-resolution human bone marrow single-cell atlas using paired […]

Conference: Curiox will be at the 39th International Clinical Cytometry Society (ICCS)

You are cordially invited to attend ICCS 2024, the 39th Annual International Clinical Cytometry Meeting & Course. Please join us from October 4-8, 2024. The ICCS Annual Course will take place at the Westin Seattle Hotel. Stop by Booth 300 to explore how our advanced solutions can transform your workflows with efficiency and precision.Whether you’re interested […]

Ex vivo T cell differentiation in adoptive immunotherapy manufacturing: Critical process parameters and analytical technologies

Sixun Chen, Tan Dai Nguyen, Kang-Zheng Lee, Dan Liu, https://doi.org/10.1016/j.biotechadv.2024.108434  Adoptive immunotherapy shows great promise as a treatment for cancer and other diseases. Recent evidence suggests that the therapeutic efficacy of these cell-based therapies can be enhanced by the enrichment of less-differentiated T cell subpopulations in the therapeutic product, giving rise to a need for […]

Meet Us at GLIIFCA 33rd Annual Meeting!

Curiox is honored to be a sponsor of this year’s GLIIFCA conference. GLIIFCA XXXIII will be September 12-14, 2024 at the Marriott Cincinnati Rivercenter in Covington, KY. We are pleased to announce that our esteemed colleague, Nadiezda Fernandez Oropeza, PhD will be presenting our latest technological advancements. This session presents an excellent opportunity to gain insights into the innovations […]

Profiling Circulating T cells and Tumor Landscape for Predicting Responses to PD-1 blockade in Patients with Non-Small Cell Lung Cancer

Dutta, N. (2024, September 5). https://gupea.ub.gu.se/handle/2077/81804 Immune checkpoint blockade (ICB) has significantly improved outcomes in non-small cell lung cancer (NSCLC), yet only a subset of patients achieves durable responses. This underscores the need for effective methods to assess ICB efficacy. This thesis investigates the response to PD-1 blockade in NSCLC patients across stages I to […]

Discover the Future of Flow Cytometry at SoCal Flow Sumit 2024

We are excited to return to the SoCal Flow Summit, happening on April 8-9, 2024, in Irvine, California! Join us on April 8th at 2:35 PM for a 15-minute presentation by Amelia McGuire, “Automating Flow Cytometry with Curiox Biosystems” She will unveil how Curiox Biosystems is revolutionizing sample preparation with our cutting-edge automation solutions. Discover […]

Breathe Easy with Better Models

Now Watching Research for Activating Macrophages and Dendritic Cells with Nanomedicine in Lung Carcinoma https://youtu.be/wljKOIcYsUM Macrophages can mediate phagocytosis of cancer cells and cytotoxic tumor killing, and engage in effective bidirectional interactions with components of the innate and adaptive immune system. Given the continuous recruitment of myelomonocytic cells into tumor tissues, macrophages are candidates for […]

Meet Us at SEFCIG 2024

Curiox Biosystems is thrilled to announce our participation in SEFCIG 2024, the Southeast Flow Cytometry Interest Group meeting, taking place from March 14-15, 2024, in Memphis, TN. This event is a key gathering for flow cytometry professionals and researchers, providing a platform to explore the latest developments, share knowledge, and engage with experts in the […]